{"protocolSection": {"identificationModule": {"nctId": "NCT01520688", "orgStudyIdInfo": {"id": "RC#5255"}, "organization": {"fullName": "West Penn Allegheny Health System", "class": "OTHER"}, "briefTitle": "Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth", "officialTitle": "A Randomized, Cross Over Study Evaluating the Effect of Flovent Discus 100 mcg BID vs QVAR 80 mcg BID vs Pulmicort Flexhaler 180 mcg BID on Short Term Growth in Pediatric Subjects With Asthma"}, "statusModule": {"statusVerifiedDate": "2020-10", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-02"}, "primaryCompletionDateStruct": {"date": "2016-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2016-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2012-01-24", "studyFirstSubmitQcDate": "2012-01-26", "studyFirstPostDateStruct": {"date": "2012-01-30", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2016-11-17", "resultsFirstSubmitQcDate": "2020-09-16", "resultsFirstPostDateStruct": {"date": "2020-10-12", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2020-10-30", "lastUpdatePostDateStruct": {"date": "2020-11-18", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Deborah Gentile", "investigatorTitle": "Principal Investigator", "investigatorAffiliation": "West Penn Allegheny Health System"}, "leadSponsor": {"name": "West Penn Allegheny Health System", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Children with mild persistent asthma that have asthma symptoms once or twice a week and use a daily controller, while children with mild intermittent asthma rarely have asthma symptoms and do not use a daily controller. Inhaled corticosteroids are the standard treatment for mild peristent asthma. The purpose of this study is to measure children rate of growth while on different inhaled corticosteroids.", "detailedDescription": "A randomized, cross over study evaluating the effect of Flovent Discus 100 mcg BID vs QVAR 80 mcg BID vs Pulmicort Flexhaler 180 mcg BID on short term growth in pediatric subjects with asthma.\n\nObjectives:\n\n1. The primary objective of this study is to compare the effect of Flovent Diskus 100 mcg BID versus Pulmicort Flexhaler 180 mcg BID on short-term lower leg growth velocity as measured by knemometry in pediatric subjects with mild asthma.\n2. The secondary objective of this study is to compare the effect of Flovent Diskus 100 mcg BID versus QVAR 80 mcg BID on short-term lower leg growth velocity as measured by knemometry in pediatric subjects with mild asthma.\n\nAims:\n\n1. The primary aim is to show that there is a growth suppressive effect of Pulmicort Flexhaler 180 mcg BID versus Flovent Diskus 100 mcg BID in children with mild asthma.\n2. The secondary aim to show that there is a growth suppressive effect of QVAR 80 mcg BID versus Flovent Diskus 100 mcg BID in children with mild asthma.\n\nHypotheses:\n\n1. The primary hypothesis is that treatment with Pulmicort Flexhaler 180mcg BID as compared to Flovent Diskus 100 mcg BID has a growth suppressive effect on lower leg length as assessed by knemometry in pediatric subjects with mild asthma.\n2. The secondary hypothesis is that treatment with QVAR 80 mcg BID as compared to Flovent Diskus 100 mcg BID has a growth suppressive effect on lower leg length as assessed by knemometry in pediatric subjects with mild asthma."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Mild persistent or mild intermittent asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "CROSSOVER", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 32, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "1 Treatment Sequence, FPQ", "type": "EXPERIMENTAL", "description": "Period 2 Flovent Diskus Period 4 Pulmicort Flexhaler Period 6 QVAR", "interventionNames": ["Drug: Fluticasone, Budesonide, Beclomethasone"]}, {"label": "2 Treatment Sequence, FQP", "type": "EXPERIMENTAL", "description": "Period 2 Flovent Diskus Period 4 QVAR Period 6 Pulmicort", "interventionNames": ["Drug: Fluticasone, Beclomethasone, Budesonide"]}, {"label": "3 Treatment Sequence, PFQ", "type": "EXPERIMENTAL", "description": "Period 2 Pulmicort Period 4 Flovent Period 6 QVAR", "interventionNames": ["Drug: Budesonide, Fluticasone, Beclomethasone"]}, {"label": "4-Treatment Sequence, PQF", "type": "EXPERIMENTAL", "description": "Period 2 Pulmicort Period 4 QVAR Period 6 Flovent", "interventionNames": ["Drug: Budesonide, Beclomethasone, Fluticasone"]}, {"label": "5 Treatment Sequence, QFP", "type": "EXPERIMENTAL", "description": "Period 2 QVAR Period 4 Flovent Period 6 Pulmicort", "interventionNames": ["Drug: Beclomethasone, Fluticasone, Budesonide"]}, {"label": "6 Treatment Sequence, QPF", "type": "EXPERIMENTAL", "description": "Period 2 QVAR Period 4 Pulmicort Period 6 Flovent", "interventionNames": ["Drug: Beclomethasone, Budesonide, Fluticasone"]}], "interventions": [{"type": "DRUG", "name": "Fluticasone, Budesonide, Beclomethasone", "description": "Fluticasone 100 mcg bid Budesonide 180 mcg bid Beclomethasone 80 mcg bid", "armGroupLabels": ["1 Treatment Sequence, FPQ"], "otherNames": ["Flovent Diskus", "Pulmicort Flexhaler", "QVAR"]}, {"type": "DRUG", "name": "Fluticasone, Beclomethasone, Budesonide", "description": "Fluticasone 100mcg BID Beclomethasone 80 mcg BID Budesonide 180 mcg BID", "armGroupLabels": ["2 Treatment Sequence, FQP"], "otherNames": ["Flovent Diskus", "Pulmicort Flexhaler", "QVAR"]}, {"type": "DRUG", "name": "Budesonide, Fluticasone, Beclomethasone", "description": "Budesonide180 mcg BID Fluticasone 100 mcg Beclomethasone 80 mcg BID", "armGroupLabels": ["3 Treatment Sequence, PFQ"], "otherNames": ["Pulmicort Flexhaler", "Flovent Diskus", "QVAR"]}, {"type": "DRUG", "name": "Budesonide, Beclomethasone, Fluticasone", "description": "Budesonide 180 mcg BID Beclomethasone 80mcg BID Fluticasone 100mcg BID", "armGroupLabels": ["4-Treatment Sequence, PQF"], "otherNames": ["Pulmicort Flexhaler", "QVAR", "Flovent Diskus"]}, {"type": "DRUG", "name": "Beclomethasone, Fluticasone, Budesonide", "description": "Beclomethasone 80 mcg BID Fluticasone 100mcg BID Budesonide 180 mcg BID", "armGroupLabels": ["5 Treatment Sequence, QFP"], "otherNames": ["QVAR", "Flovent Diskus", "Pulmicort Flexhaler"]}, {"type": "DRUG", "name": "Beclomethasone, Budesonide, Fluticasone", "description": "Beclomethasone 80mcg BID Budesonide 180 mcg BID Fluticasone 100mcg BID", "armGroupLabels": ["6 Treatment Sequence, QPF"], "otherNames": ["QVAR", "Pulmicort Flexhaler", "flovent Diskus"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Short-term Lower Leg Growth During Treatment With Flovent Diskus 100 mcg BID or Pulmicort Flexhaler 180 mcg BID.", "description": "Short-term lower leg growth as assessed by knemometry in pediatric subjects with mild asthma treated with Flovent Discus 100 mcg BID or Pulmicort Flexhaler 180 mcg BID.", "timeFrame": "1 yr"}], "secondaryOutcomes": [{"measure": "Short-term Lower Leg Growth During Treatment With Flovent Discus 100 mcg BID or QVAR 80 mcg BID.", "description": "Short-term lower leg growth as assessed by knemometry in pediatric subjects with mild asthma during treatment with Flovent Discus 100 mcg BID or QVAR 80 mcg BID.", "timeFrame": "1 yr"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Subjects will include females (6 to 9 years of age) and males (6 to 11 years of age).\n2. All subjects must have a history of physician diagnosed mild intermittent or mild persistent asthma as documented by PCP medical record or detailed history by study investigator.\n3. All subjects must have a height within normal limits (5th to 95th percentile) and no history of abnormal growth as assessed by medical history.\n4. All subjects must be pre-pubertal (Tanner Stage 1 Sexual Maturity) as assessed by physical examination.\n5. Subjects may be on current treatment with montelukast as this drug does not affect growth. If a subject is on montelukast at screening/baseline, they will remain on a stable dose throughout the study.\n6. Subjects must be willing to comply with study requirements.\n\nExclusion Criteria:\n\n1. Subjects will be excluded if they have asthma greater than mild persistent severity as defined by NHLBI guidelines.\n2. Subjects will be excluded if they used any systemic or nasal steroids within the past 60 days.\n3. Subjects will be excluded if they had more than one burst of systemic steroids within the past year.\n4. Subjects will be excluded if their baseline FEV1 is \\< 80% predicted.\n5. Subjects will be excluded if they have any other serious systemic disease other than asthma.\n6. Subjects will be excluded if they have taken any medication known to affect growth i.e. ADHD medications within the past 60 days\n7. Subjects will be excluded if they have a history of allergy to any of the study medications, milk protein or lactose.\n8. Subjects will be excluded if they have active chickenpox or measles or recent exposure to chickenpox or measles.\n9. Subjects will be excluded if they have any history of tuberculosis of the respiratory tract.\n10. Subjects will be excluded if they have any active fungal, bacterial, viral or parasitic infections.\n11. Subjects will be excluded if they have any history of herpes simplex infection of the eye.\n12. Subjects will be excluded if they have taken any immunosuppressive drugs within the past 2 months.\n13. Subjects will be excluded if they have any history of Churg-Strauss syndrome or other eosinophilic disorders.\n14. Subjects will be excluded if an investigator deems they have any mental or development health issues, such as autism, moderate to severe mental retardation or severe ADHD,that interferes with their ability to complete the knemometry measurements.\n15. Subjects will be excluded if an investigator deems they have any physical issues, such as inability to sit independently or amputation of lower leg, that interferes with their ability to complete the knemometry measurements.", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "6 Years", "maximumAge": "11 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Deborah A Gentile, MD", "affiliation": "Allegheny Singer Research Institute/Allegheny General Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Pediatric Alliance-Greentree Division", "city": "Green Tree", "state": "Pennsylvania", "zip": "15220", "country": "United States", "geoPoint": {"lat": 40.41174, "lon": -80.04561}}, {"facility": "Allegheny General Hospital", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "1 Treatment Sequence, FPQ", "description": "Period 2 Flovent Diskus Period 4 Pulmicort Flexhaler Period 6 QVAR\n\nFluticasone, Budesonide, Beclomethasone: Fluticasone 100 mcg bid Budesonide 180 mcg bid Beclomethasone 80 mcg bid"}, {"id": "FG001", "title": "2 Treatment Sequence, FQP", "description": "Period 2 Flovent Diskus Period 4 QVAR Period 6 Pulmicort\n\nFluticasone, Beclomethasone, Budesonide: Fluticasone 100mcg BID Beclomethasone 80 mcg BID Budesonide 180 mcg BID"}, {"id": "FG002", "title": "3 Treatment Sequence, PFQ", "description": "Period 2 Pulmicort Period 4 Flovent Period 6 QVAR\n\nBudesonide, Fluticasone, Beclomethasone: Budesonide180 mcg BID Fluticasone 100 mcg Beclomethasone 80 mcg BID"}, {"id": "FG003", "title": "4-Treatment Sequence, PQF", "description": "Period 2 Pulmicort Period 4 QVAR Period 6 Flovent\n\nBudesonide, Beclomethasone, Fluticasone: Budesonide 180 mcg BID Beclomethasone 80mcg BID Fluticasone 100mcg BID"}, {"id": "FG004", "title": "5 Treatment Sequence, QFP", "description": "Period 2 QVAR Period 4 Flovent Period 6 Pulmicort\n\nBeclomethasone, Fluticasone, Budesonide: Beclomethasone 80 mcg BID Fluticasone 100mcg BID Budesonide 180 mcg BID"}, {"id": "FG005", "title": "6 Treatment Sequence, QPF", "description": "Period 2 QVAR Period 4 Pulmicort Period 6 Flovent\n\nBeclomethasone, Budesonide, Fluticasone: Beclomethasone 80mcg BID Budesonide 180 mcg BID Fluticasone 100mcg BID"}, {"id": "FG006", "title": "Enrolled But Not Randomized.", "description": "These subjects were consented but not randomized."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "5"}, {"groupId": "FG004", "numSubjects": "5"}, {"groupId": "FG005", "numSubjects": "5"}, {"groupId": "FG006", "numSubjects": "5"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "4"}, {"groupId": "FG005", "numSubjects": "5"}, {"groupId": "FG006", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}, {"groupId": "FG005", "numSubjects": "0"}, {"groupId": "FG006", "numSubjects": "5"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "All Study Participants"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "27"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "8.4", "spread": "1.57"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "5"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "22"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "2"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "25"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "27"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Short-term Lower Leg Growth During Treatment With Flovent Diskus 100 mcg BID or Pulmicort Flexhaler 180 mcg BID.", "description": "Short-term lower leg growth as assessed by knemometry in pediatric subjects with mild asthma treated with Flovent Discus 100 mcg BID or Pulmicort Flexhaler 180 mcg BID.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mm/wk", "timeFrame": "1 yr", "groups": [{"id": "OG000", "title": "Flovent Discus 100 mcg BID"}, {"id": "OG001", "title": "Pulmicort Flexhaler 180 mcg BID"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "27"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.37", "lowerLimit": "0.21", "upperLimit": "0.53"}, {"groupId": "OG001", "value": "0.21", "lowerLimit": "0.05", "upperLimit": "0.37"}]}]}]}, {"type": "SECONDARY", "title": "Short-term Lower Leg Growth During Treatment With Flovent Discus 100 mcg BID or QVAR 80 mcg BID.", "description": "Short-term lower leg growth as assessed by knemometry in pediatric subjects with mild asthma during treatment with Flovent Discus 100 mcg BID or QVAR 80 mcg BID.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mm/wk", "timeFrame": "1 yr", "groups": [{"id": "OG000", "title": "Flovent Discus 100 mcg BID"}, {"id": "OG001", "title": "QVAR 80 mcg BID"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "27"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.37", "lowerLimit": "0.21", "upperLimit": "0.53"}, {"groupId": "OG001", "value": "0.38", "lowerLimit": "0.22", "upperLimit": "0.54"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Flovent Discus 100 mcg BID", "deathsNumAffected": 0, "deathsNumAtRisk": 27, "seriousNumAffected": 0, "seriousNumAtRisk": 27, "otherNumAffected": 7, "otherNumAtRisk": 27}, {"id": "EG001", "title": "Pulmicort Flexhaler 180 mcg BID", "deathsNumAffected": 0, "deathsNumAtRisk": 27, "seriousNumAffected": 0, "seriousNumAtRisk": 27, "otherNumAffected": 6, "otherNumAtRisk": 27}, {"id": "EG002", "title": "QVAR 80 mcg BID", "deathsNumAffected": 0, "deathsNumAtRisk": 27, "seriousNumAffected": 0, "seriousNumAtRisk": 27, "otherNumAffected": 7, "otherNumAtRisk": 27}], "otherEvents": [{"term": "Colds/viral illnesses", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 7, "numAtRisk": 27}]}, {"term": "Headaches", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 3, "numAtRisk": 27}]}, {"term": "Respiratory infections", "organSystem": "Respiratory, thoracic and mediastinal disorders", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 27}]}, {"term": "Worsening allergies", "organSystem": "Immune system disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 27}]}, {"term": "Bodily injuries", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 27}]}, {"term": "Asthma exacerbation", "organSystem": "Immune system disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 27}]}, {"term": "Ear infection", "organSystem": "Ear and labyrinth disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 27}]}, {"term": "Sinus infection", "organSystem": "General disorders", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 27}]}, {"term": "Pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 27}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 27}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 27}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Deborah Gentile, MD", "organization": "Allegheny Health Network", "email": "dgentile@ahn.org", "phone": "412-359-4099"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "T4202", "name": "Oculocerebral Syndrome With Hypopigmentation", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "C000716389", "term": "Xhance"}, {"id": "D000019819", "term": "Budesonide"}, {"id": "D000001507", "term": "Beclomethasone"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}], "browseLeaves": [{"id": "M21711", "name": "Budesonide", "asFound": "Of 1", "relevance": "HIGH"}, {"id": "M4800", "name": "Beclomethasone", "asFound": "Domains", "relevance": "HIGH"}, {"id": "M250", "name": "Fluticasone", "asFound": "Pembrolizumab", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "asFound": "Pembrolizumab", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}]}}, "hasResults": true}